ATE47314T1 - Anti-legionella monoklonale antikoerper, verfahren zur herstellung derselben und anwendung fuer die dosierung von legionella pneumophila. - Google Patents

Anti-legionella monoklonale antikoerper, verfahren zur herstellung derselben und anwendung fuer die dosierung von legionella pneumophila.

Info

Publication number
ATE47314T1
ATE47314T1 AT84400348T AT84400348T ATE47314T1 AT E47314 T1 ATE47314 T1 AT E47314T1 AT 84400348 T AT84400348 T AT 84400348T AT 84400348 T AT84400348 T AT 84400348T AT E47314 T1 ATE47314 T1 AT E47314T1
Authority
AT
Austria
Prior art keywords
legionella
monoclonal antibodies
production
dosing
application
Prior art date
Application number
AT84400348T
Other languages
English (en)
Inventor
Jean Gerard Guillet
Johan Hoebeke
Cuong Tram
Donny A Strosberg
Original Assignee
Centre Nat Rech Scient
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Pasteur Institut filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE47314T1 publication Critical patent/ATE47314T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/126—Legionella (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT84400348T 1983-02-21 1984-02-20 Anti-legionella monoklonale antikoerper, verfahren zur herstellung derselben und anwendung fuer die dosierung von legionella pneumophila. ATE47314T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8302789A FR2541304A1 (fr) 1983-02-21 1983-02-21 Anticorps monoclonaux anti-legionella, procede d'obtention et application au diagnostic de pneumonies
EP84400348A EP0119893B1 (de) 1983-02-21 1984-02-20 Anti-legionella monoklonale Antikörper, Verfahren zur Herstellung derselben und Anwendung für die Dosierung von Legionella Pneumophila

Publications (1)

Publication Number Publication Date
ATE47314T1 true ATE47314T1 (de) 1989-11-15

Family

ID=9286117

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84400348T ATE47314T1 (de) 1983-02-21 1984-02-20 Anti-legionella monoklonale antikoerper, verfahren zur herstellung derselben und anwendung fuer die dosierung von legionella pneumophila.

Country Status (8)

Country Link
US (1) US4780407A (de)
EP (1) EP0119893B1 (de)
JP (1) JPS59192092A (de)
AT (1) ATE47314T1 (de)
CA (1) CA1217439A (de)
DE (1) DE3480173D1 (de)
FR (1) FR2541304A1 (de)
IL (1) IL70993A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537272A1 (de) * 1985-10-19 1987-04-23 Progen Biotechnik Gmbh Monoklonaler antikoerper, der mit legionella pneumophila reagiert
GB8610203D0 (en) * 1986-04-25 1986-05-29 Technology Licence Co Ltd Monoclonal antibodies
US5108745B1 (en) * 1988-08-16 1998-06-30 Univ California Tuberculosis and legionellosis vaccines and methods for their production
FR2674866A1 (fr) * 1991-04-08 1992-10-09 Chemunex Anticorps anti-ace et leurs applications a la detection specifique et eventuellement a la numeration des enterobacteries entieres, par une methode immunochimique.
RU2129279C1 (ru) * 1995-11-23 1999-04-20 Государственный научный центр прикладной микробиологии Диагностикум для идентификации легионелл в клиническом материале и объектах внешней среды и способ его получения
US20080081347A1 (en) * 1998-08-25 2008-04-03 Binax, Inc. EIA for Monitoring Legionella Pneumophila Presence in Water Samples
US6824997B1 (en) 1998-09-18 2004-11-30 Binax, Inc. Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
US20080096236A1 (en) * 1998-08-25 2008-04-24 Binax, Inc. Method for Detecting the Presence of Target Bacteria or a Target Component Carbohydrate Antigen Thereof
US9134303B1 (en) * 1998-08-25 2015-09-15 Alere Scarborough, Inc. ICT immunoassay for Legionella pneumophila serogroup 1 antigen employing affinity purified antibodies thereto
WO2001042791A1 (en) * 1999-12-10 2001-06-14 Binax, Inc. Eia for monitoring legionella pneumophila presence in water samples
US7901932B2 (en) * 2005-03-17 2011-03-08 Phigenics, Llc Methods and compositions for rapidly detecting and quantifying viable Legionella
MX2007011189A (es) * 2005-03-17 2008-01-16 Phigenics Llc Deteccion y cuantificacion rapida de legionella viable.
AU2006329963B2 (en) * 2005-12-06 2011-06-09 Amgen Inc. Polishing steps used in multi-step protein purification processes
RU2699983C1 (ru) * 2018-12-04 2019-09-11 Федеральное бюджетное учреждение науки "Государственный научный центр прикладной микробиологии и биотехнологии" (ФБУН ГНЦ ПМБ) Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Штамм гибридных культивируемых клеток животных Mus musculus 1F11PAL - продуцент мышиных моноклональных антител, специфичных к пептидогликан-ассоциированному липопротеину (PAL) Legionella pneumophila

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies

Also Published As

Publication number Publication date
DE3480173D1 (en) 1989-11-23
FR2541304A1 (fr) 1984-08-24
CA1217439A (fr) 1987-02-03
IL70993A0 (en) 1984-05-31
JPS59192092A (ja) 1984-10-31
EP0119893B1 (de) 1989-10-18
FR2541304B1 (de) 1985-05-17
IL70993A (en) 1988-05-31
EP0119893A1 (de) 1984-09-26
US4780407A (en) 1988-10-25

Similar Documents

Publication Publication Date Title
ATE47314T1 (de) Anti-legionella monoklonale antikoerper, verfahren zur herstellung derselben und anwendung fuer die dosierung von legionella pneumophila.
ATE4778T1 (de) Verfahren zur herstellung von hepatitisvirusantik\rpern und zellstaemme hierfuer.
ATE13317T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches prothymozytantigen; antikoerper und verfahren zu seiner herstellung; diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
ES8105151A1 (es) Un metodo para la preparacion de un anticuerpo monoclonico.
ATE14233T1 (de) Monoklonaler antikoerper gegen menschliche tzellen, verfahren zu seiner herstellung, ihn produzierende hybridzellinie, ihn enthaltende therapeutische zusammensetzung und ihn verwendendes diagnostisches verfahren.
ATE14023T1 (de) Einen monoklonalen antikoerper produzierende hybridzellinie, antikoerper und verfahren zu seiner herstellung, diesen antikoerper enthaltende therapeutische zusammensetzung und deren diagnostische und therapeutische verwendungen.
ATE58554T1 (de) Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper.
ATE13198T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches t-zellenantigen, antikoerper und verfahren.
ES8303095A1 (es) Un metodo de preparacion de un inticuerpo monocloral.
ES526097A0 (es) Un procedimiento para obtener anticuerpos monoclonales humanos contra toxina bacteriana
ES8504461A1 (es) Un procedimiento para obtener un polidoma.
ES497424A0 (es) Un metodo de preparacion de un anticuerpo monoclonal.
ES8200559A1 (es) Un anticuerpo monoclonal
IL61863A (en) Monoclonal antibody to a human monocyte antigen,its production and diagnostic and pharmaceutical compositions contaiing it
DE68924773D1 (de) Monoklonale antikörper gegen den bereich der leichten kette von menschlichem faktor xii sowie methoden zu deren herstellung und verwendung.
DE3582358D1 (de) Monoklonaler antikoerper und verfahren zur quantitativen bestimmung von immunoglobulinen mittels dieses antikoerpers.
ATE70310T1 (de) Verfahren zur herstellung von monoklonalen antikoerpern gegen hbsag.
DE3783002D1 (de) Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega.
ATA168387A (de) Verfahren zur herstellung von zellinien, die monoklonale antikörper produzieren
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
ES8609465A1 (es) Procedimiento para preparar nuevos anticuerpos monoclonales de raton con especificidad anti-interferon de humano
RU92016461A (ru) Культура, линия клеток, моноклональные антитела, способ получения моноклональных антител, способ лечения, способ диагностики
UA32341A (uk) Спосіб одержання антиадгезивної та антитоксичної сироватки проти сальмонельозів та ешерихіозів тварин

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties